UICC Opens the World Cancer Leaders’ Summit 2025

World Cancer Leaders UICC

Top Growing Medical Universities in USA and Canada: 2025 Edition by BIGR

USA and Canada

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 influential women in oncology

The 9th CAR-TCR Summit: Advancing the Next Era of Engineered Cell Therapies

9th-CAR-TCR-Summit-Europe-2026-1280x720

10 Oncology Experts Join OncoDaily Medical Journal’s Editorial Team

OncoDaily Medical Journal

Tomislav Mihaljevic: $14.5M Raised for VeloSano to Support Cancer Research at Cleveland Clinic

Cleveland Clinic

Joshua Budhu: Multidisciplinary Review in Post-Radiation Brain Metastasis Evaluation

joshua budhu

FDA Immunotherapy Approvals: First Half of 2025

FDA Immunotherapy Approvals: First Half of 2025

OncoCalendar

« All Events

  • This event has passed.

2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium

May 21 • 8:00 AM - May 22 • 5:00 PM
2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium

2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will be held from May 21-22, 2025 at Houston, Texas.

The 2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will bring together global experts to explore the latest advancements in MDS research and treatment. This event focuses on the biological mechanisms of hematopoietic stem cells in both normal and disease states, aiming to deepen understanding and improve therapeutic strategies for MDS.

Attendees will gain insights into cutting-edge diagnostics, molecular findings, and innovative treatment approaches. The symposium fosters collaboration and knowledge exchange to advance progress in managing this complex hematologic malignancy.

Registration is open for the event.

Details

Organizer

Venue